908 Devices Inc. (NASDAQ:MASS) CEO Kevin J. Knopp Buys 10,000 Shares

908 Devices Inc. (NASDAQ:MASS - Get Free Report) CEO Kevin J. Knopp purchased 10,000 shares of the business's stock in a transaction on Thursday, May 9th. The shares were bought at an average price of $5.83 per share, for a total transaction of $58,300.00. Following the purchase, the chief executive officer now directly owns 488,981 shares in the company, valued at approximately $2,850,759.23. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

908 Devices Trading Up 1.1 %

Shares of MASS stock traded up $0.06 during trading hours on Thursday, hitting $5.76. The company's stock had a trading volume of 451,852 shares, compared to its average volume of 181,132. The company has a 50 day moving average of $6.41 and a 200 day moving average of $7.07. The stock has a market cap of $189.96 million, a PE ratio of -5.33 and a beta of 1.02. 908 Devices Inc. has a 12-month low of $4.85 and a 12-month high of $12.51.

908 Devices (NASDAQ:MASS - Get Free Report) last posted its quarterly earnings results on Tuesday, April 30th. The company reported ($0.33) earnings per share for the quarter, topping the consensus estimate of ($0.36) by $0.03. The firm had revenue of $9.99 million for the quarter, compared to the consensus estimate of $9.29 million. 908 Devices had a negative net margin of 68.57% and a negative return on equity of 20.47%. The company's revenue for the quarter was up 5.3% on a year-over-year basis. During the same period last year, the firm posted ($0.39) earnings per share. As a group, analysts anticipate that 908 Devices Inc. will post -1.11 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in MASS. AWM Investment Company Inc. acquired a new position in shares of 908 Devices in the third quarter valued at approximately $3,740,000. ARK Investment Management LLC grew its holdings in shares of 908 Devices by 8.3% in the fourth quarter. ARK Investment Management LLC now owns 4,346,579 shares of the company's stock valued at $48,769,000 after purchasing an additional 333,119 shares in the last quarter. Iron Triangle Partners LP grew its holdings in shares of 908 Devices by 31.1% in the fourth quarter. Iron Triangle Partners LP now owns 1,284,947 shares of the company's stock valued at $14,417,000 after purchasing an additional 304,484 shares in the last quarter. Granahan Investment Management LLC grew its holdings in shares of 908 Devices by 10.6% in the fourth quarter. Granahan Investment Management LLC now owns 2,038,658 shares of the company's stock valued at $22,874,000 after purchasing an additional 195,368 shares in the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. grew its holdings in 908 Devices by 3.0% during the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 629,994 shares of the company's stock worth $4,196,000 after acquiring an additional 18,492 shares in the last quarter. Institutional investors and hedge funds own 88.06% of the company's stock.

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.